Due to its well-characterised molecular profile and broad scientific interest, AOD-9604 remains a frequently referenced compound within peptide-focused research programmes
This creates real risks: Peptides with low purity or incorrect dosing Contaminated vials or bacterial growth Counterfeit labeling To mitigate these risks, users often seek third-party tested suppliers or work through practitioners in peptide-friendly clinics that adhere to sterile compounding standards
Most vials have 1000 mcg/mL
Composed of 23 amino acids in a D-amino acid configuration, this cell-penetrating peptide represents a novel therapeutic approach to addressing cellular senescence, a fundamental driver of aging and age-related diseases
Part of the reason is that anti-TNF agents block one specific cytokine while leaving the rest of the inflammatory network intact
It is not intended for human consumption, therapeutic, or diagnostic use.